Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease; Penthrox, a trauma and emergency pain relief product; and medical devices, such as CPR face...
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers.
Target Price
The average target price of MVP.AX is 2.1 and suggests 242% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell